Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alex azar
allergan
alliance for aging research
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biotech
biotechnology innovation organization
What
plans
2
×
acquisitions
administration
angry
announced
anti
benefited
bio
ceo
collabs
covid
daniel
deal
despite
drug
fear
gilead
gilead’s
help
industry
introduce
ipo
losing
medicines
month
o’day
pharma
presidential
price
rhetoric
roundup
rx
scalps
sciences
split
thanks
transformative
trump
tweets
years
Language
unset
Current search:
biogen
×
plans
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
